n-(2-aminoethyl)-5-isoquinolinesulfonamide has been researched along with Anemia, Fanconi in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voter, AF | 1 |
| Manthei, KA | 1 |
| Keck, JL | 1 |
| Chirnomas, D | 1 |
| Taniguchi, T | 1 |
| de la Vega, M | 1 |
| Vaidya, AP | 1 |
| Vasserman, M | 1 |
| Hartman, AR | 1 |
| Kennedy, R | 1 |
| Foster, R | 1 |
| Mahoney, J | 1 |
| Seiden, MV | 1 |
| D'Andrea, AD | 1 |
2 other studies available for n-(2-aminoethyl)-5-isoquinolinesulfonamide and Anemia, Fanconi
| Article | Year |
|---|---|
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanc | 2016 |
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.
Topics: Androstadienes; Benzazepines; BRCA1 Protein; Cell Survival; Cisplatin; Curcumin; DNA Damage; Fanconi | 2006 |